The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
Chu
C-Y
CY
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000368:Aged; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012393:Rosacea / Q000139:chemically induced / Q000188:drug therapy*; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; C117268:pimecrolimus; D016559:Tacrolimus